Within the Translational Cancer Genomics group, Patricia works on large-scale combination drug screens in cancer cell lines to establish a combination drug screen analysis framework and to identify novel cancer therapies and genetic biomarkers of synergy.
My timeline
Postdoctoral Fellow at the Wellcome Trust Sanger Institute
Awarded PhD from University of Zurich, Switzerland PhD project: 'The proprotein convertase furin is a key regulator of paediatric sarcoma malignancy', University Children's Hospital Zurich
Graduated from Imperial College London, UK, MSc Molecular Medicine
Graduated from University of Hamburg, Germany, BSc Molecular Life Sciences
My publications
Connect with me on Twitter
Cheers @fiona_fb3 for the nomination. Day 7/7 #mylifeinpictures. Rules: no words, no people. Today I nominate @manueltard
Cheers @fiona_fb3 for the nomination. Day 6/7 #mylifeinpictures. Rules: no people, no words. Today I nominate @EricaBello4
🧬 The Sanger Institute was opened in 1992 to be a major contributor to the Human Genome Project.
#OTD 2000, the first draft was published, revolutionising biological research as we know it 🔬🧪🦠🧫
#HumanGenome20
